Extension of a Project Period Without Additional Funds:

The grantee may extend the final budget period of the project period one time for a period of up to 12 months beyond the original expiration date shown in the NGA if no additional funds are required to be obligated by the NIH awarding office, there will be no change in the project’s originally approved scope, and any one of the following applies:

• Additional time beyond the established expiration date is required to ensure adequate completion of the originally approved project.
• Continuity of NIH grant support is required while a competing continuation application is under review.
• The extension is necessary to permit an orderly phase-out of a project that will not receive continued support.

在赠款到期时仍保留资金的事实本身并没有足够的延期理由，而没有额外的资金。

The grantee must notify the NIH awarding office, in writing, of the extension ten days prior to the expiration date of the project period. Upon notification, the NIH awarding office will revise the project period ending date and provide an acknowledgement to the grantee. In extending the final budget period of the project period through this process, the grantee agrees to update all required certifications, including human subjects and animal welfare, in accordance with the applicable regulations and policies. Grantees may not extend project periods previously extended by the NIH awarding office. Any additional project period extension beyond the one-time extension of up to 12 months requires NIH prior approval. (See the “Prior Approval Requirements” section above.)

Use of Program Income:

The additive costs alternative for the use of program income applies to awards subject to expanded authorities unless the NGA specifies another alternative or the grantee is a for-profit organization other than an SBIR/STTR awardee. For-profit organizations other than SBIR/STTR awardees are subject to the deductive alternative. (See the NIH’s website under “Administrative Requirements – Management Systems and Procedures – Program Income.”)

Carryover of Un-obligated Balances:

Except for funds restricted in an NoA, unobligated funds remaining at the end of a budget period are automatically carried over. For awards under the Streamlined Non-Competing Award Process (SNAP), funds are automatically carried over and are available for expenditure during the entire project period. However, under those awards, the grantee will be required to indicate, as part of its non-competing continuation request, whether its estimated unobligated balance (including prior year carryover) is expected to be greater than 25% of the current year’s total budget. If so, the grantee must provide an explanation and indicate plans for expenditure of those funds if carried forward. (See the NIH’s website under “Administrative Requirements – Non-Competing Continuation Awards.”)

For those awards subject to expanded authorities but excluded from SNAP (e.g. P01s and R35s), the FSR must specify the amount to be carried over. The notification must be provided under item 12, “Remarks,” on the FSR. When a grantee reports a balance of unobligated funds in excess of 25% of the total amount awarded, the GMO will review the circumstances resulting in the balance to ensure that these funds are necessary to complete the project, and may request additional information from the grantee, including a revised budget, as part of the review. If the GMO determines that some or all of the unobligated funds are not necessary to complete the project, the GMO may take one, or a combination, of the following actions:

• Restrict the grantee’s authority to automatically carry over unobligated balances in the future.
• Use the balance to reduce or offset NIH funding for a subsequent budget period. Any amount not identified for carryover may be used as an offset. A revised NGA will not be issued to reflect the carryover.

与成本有关的事先批准，包括患者护理和设备：

NIH批准这些个人费用的批准的要求，包括对它们的辩护，除非它们构成范围的变更，否则不适用。

传输性能的实质性的总结mmatic work to a Third Party by Means of a Consortium Agreement, Contract, or Other Means:

在扩大的当局下，不需要受赠人获得NIH事先批准以转移实质性程序化工作的绩效，除非该活动构成范围的变化或导致将实质性程序化工作转移到外国组件。

请求批准

必须以书面形式（包括电子邮件提交）向指定的GMO提交NIH授予办公室的所有请求，不迟于项目终止日期前30天。

注意：将所有请求发送给PAF团队，该团队将确保该团队获得资金机构。